FDA’s Past, Present & Future with John Taylor

FDA's Past, Present & Future with John Taylor – FDA Watch

Wayne chats with John Taylor, Head of the Quality and Compliance Practice at ELIQUENT and 30-year FDA, industry, trade association, and consulting veteran. Together, they discuss Taylor's pedigree; his perspective on the most pressing issues FDA is facing in drugs, devices, foods, and cosmetics; the agency's increasing use of AI; what FDA's top priorities should be moving forward; and much more. This episode and all bonus episodes do not include the usual Headlines and Resources Links segments. To subscribe or find out more information about our podcast, visit FDAWatch.net. Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at info@fdawatch.net. Music by Dvir Silver from Pixabay.

Listen on Spotify

Listen on Apple Podcasts

Wayne chats with John Taylor, Head of the Quality and Compliance Practice at ELIQUENT and 30-year FDA, industry, trade association, and consulting veteran. Together, they discuss Taylor’s pedigree; his perspective on the most pressing issues FDA is facing in drugs, devices, foods, and cosmetics; the agency’s increasing use of AI; what FDA’s top priorities should be moving forward; and much more.

This episode and all bonus episodes do not include the usual Headlines and Resources Links segments.

About Our Guest

John Taylor

John Taylor is the Head of the Quality and Compliance Practice at ELIQUENT, where he is responsible for guiding efforts to provide strategic guidance and advice to life science companies on quality and compliance issues that impact their ability to develop innovative solutions to public health challenges around the world.

For more than 30 years, John Taylor has made significant contributions to the public health, serving in senior leadership positions within the Food and Drug Administration (FDA), industry, trade association, and consulting services. John joined ELIQUENT (formerly Greenleaf Health) following a distinguished career of more than 20 years at the FDA. During John’s time at the Agency, he led several of its priority initiatives. At ELIQUENT, John continues his commitment to health care innovation as the head of ELIQUENT’s Quality and Compliance Practice. In this role, John provides strategic consultation to FDA regulated clients on enforcement, compliance, quality, and regulatory matters.

From 2009 to 2014, John held three high-profile positions at the FDA: Counselor to the Commissioner, Acting Principal Deputy Commissioner, and Acting Deputy Commissioner for Global Regulatory Operations and Policy.